Experience with the renal scintigraphic captopril test in an elderly population.
The records of 18 consecutive patients referred to a Veterans Administration Hospital nuclear medicine service for renal scintigraphic tests to rule out renovascular hypertension were reviewed. The men were elderly (mean age, 62 years), and risk factors for untoward reactions, including long-standing hypertension, severe peripheral vascular disease, diabetes, chronic renal failure, and recent diuretic use were present. Despite these risks, there was no test morbidity, and the authors conclude that the renal scintigraphic test with captopril enhancement is well tolerated and deserves continued application and evaluation.
Chaudhuri
T K
TK
Nuclear Medicine Service, Veterans Administration Medical Center, Hampton, Virginia 23667.
Fink
S
S
D000368:Aged; D002216:Captopril; D006801:Humans; D006978:Hypertension, Renovascular / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D004369:Pentetic Acid; D011866:Radioisotope Renography; D012189:Retrospective Studies; D012307:Risk Factors; D013667:Technetium; D016284:Technetium Tc 99m Pentetate
D009942:Organometallic Compounds; D013667:Technetium; D004369:Pentetic Acid; D002216:Captopril; D016284:Technetium Tc 99m Pentetate